Surgery Doctors in Whiting, IA Accepting Medicare
1 Surgery doctors found. Showing 1 - 1
 John L Garred Jr., M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 153 Blair St, Whiting, IA 51063 Phone: 712-455-2431 Fax: 712-455-2698 |
News Archive
ZEISS adds INFRARED 800 to OPMI PENTERO 800 for reconstructive surgery
ZEISS is now adding INFRARED 800 to its OPMI PENTERO 800 surgical microscope for reconstructive surgery. The new enhancements are tailored to the requirements of breast reconstruction, lymph supermicrosurgery, and oral and maxillofacial surgery. Clinical specialists can benefit from the optimized package of ZEISS OPMI PENTERO 800 which provides intraoperative assessment of blood flow, higher magnification and effortless maneuverability required for complex reconstructive surgery.
New gaming technology receives national awards
Television shows have been using tension between hospital personnel as compelling drama for years. But, in the real world, misunderstandings and miscommunication in the healthcare environment can cause errors with long-lasting, even fatal consequences.
Catholics for Choice supports coverage of reproductive healthcare services in healthcare policy
"Catholics believe that healthcare is a right, not a privilege. However, our vision for healthcare reform is different than the US bishops and their conservative allies, who seek to marginalize issues of reproductive health-as if people's reproductive health can be separated from their overall health. People in the United States need coverage of reproductive healthcare services, and efforts to deny this coverage based on the opinions of a small but vocal minority are unjust.
FibroGen initiates FG-3019 open-label phase 2 study in idiopathic pulmonary fibrosis
FibroGen, Inc. today announced initiation of an open-label phase 2 study to evaluate the safety, tolerability, and efficacy of FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), in individuals with idiopathic pulmonary fibrosis (IPF), a chronic, progressive, fatal lung disease for which there are no FDA-approved therapies.
Karolinska Institutet study may lead to development of better immune-based cancer therapies
A study by researchers at Sweden's Karolinska Institutet is the first to suggest that cells in the tumour blood vessels contribute to a local environment that protects the cancer cells from tumour-killing immune cells. The results, which are being published in the 'Journal of the National Cancer Institute', can contribute to the development of better immune-based cancer therapies.
› Verified 9 days ago